These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 14550856)

  • 1. An overview of the recent trends in development of HPLC methods for determination of impurities in drugs.
    Nageswara Rao R; Nagaraju V
    J Pharm Biomed Anal; 2003 Oct; 33(3):335-77. PubMed ID: 14550856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in derivatization methods for LC and CE analysis.
    Fukushima T; Usui N; Santa T; Imai K
    J Pharm Biomed Anal; 2003 Jan; 30(6):1655-87. PubMed ID: 12485710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of 4-aminophenol impurities in multicomponent analgesic preparations by HPLC with amperometric detection.
    Wyszecka-Kaszuba E; Warowna-Grześkiewicz M; Fijałek Z
    J Pharm Biomed Anal; 2003 Aug; 32(4-5):1081-6. PubMed ID: 12899997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of the recent developments in analytical methodologies for determination of COX-2 inhibitors in bulk drugs, pharmaceuticals and biological matrices.
    Nageswara Rao R; Meena S; Raghuram Rao A
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):349-63. PubMed ID: 16009523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective determination of potential impurities in an active pharmaceutical ingredient using HPLC-SPE-HPLC.
    Yamamoto E; Niijima J; Asakawa N
    J Pharm Biomed Anal; 2013 Oct; 84():41-7. PubMed ID: 23806999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between HPLC precision and number of significant figures when reporting impurities and when setting specifications.
    Agut C; Segalini A; Bauer M; Boccardi G
    J Pharm Biomed Anal; 2006 May; 41(2):442-8. PubMed ID: 16472956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Overview of Advances in the Chromatography of Drugs Impurity Profiling.
    ALSaeedy M; Al-Adhreai A; Öncü-Kaya EM; Şener E
    Crit Rev Anal Chem; 2023; 53(7):1455-1471. PubMed ID: 35180027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a LC-LC-MS complete heart-cut approach for the characterization of pharmaceutical compounds using standard instrumentation.
    Sheldon EM
    J Pharm Biomed Anal; 2003 Apr; 31(6):1153-66. PubMed ID: 12667931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal phase and reverse phase HPLC-UV-MS analysis of process impurities for rapamycin analog ABT-578: application to active pharmaceutical ingredient process development.
    Chen Y; Brill GM; Benz NJ; Leanna MR; Dhaon MK; Rasmussen M; Zhou CC; Bruzek JA; Bellettini JR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):106-17. PubMed ID: 17826364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UPLC: a preeminent technique in pharmaceutical analysis.
    Kumar A; Saini G; Nair A; Sharma R
    Acta Pol Pharm; 2012; 69(3):371-80. PubMed ID: 22594250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the detection of degradants and impurities in pharmaceutical drug products by applying mass spectral and chromatographic searching.
    Freed AL; Kale U; Ando H; Rossi DT; Kingsmill CA
    J Pharm Biomed Anal; 2004 Jun; 35(4):727-38. PubMed ID: 15193717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of impurities level of perindopril tert-butylamine in tablets.
    Medenica M; Ivanović D; Masković M; Jancić B; Malenović A
    J Pharm Biomed Anal; 2007 Sep; 44(5):1087-94. PubMed ID: 17590561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of d-Cycloserine Impurities in Pharmaceutical Dosage Forms: Comparison of the International Pharmacopoeia HPLC-UV Method and the DOSY NMR Method.
    Makuc D; Švab Ž; Naumoska K; Plavec J; Časar Z
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32272592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impurity Profile of Bronchodilators used in Asthma: A Critical Review.
    Prajapati KJ; Kothari CS
    Curr Drug Discov Technol; 2018; 15(4):272-304. PubMed ID: 28875855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of local anaesthetics and their impurities in pharmaceutical preparations using HPLC method with amperometric detection.
    Fijałek Z; Baczyński E; Piwońska A; Warowna-Grześkiewicz M
    J Pharm Biomed Anal; 2005 Apr; 37(5):913-8. PubMed ID: 15862666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-MS characterization of trace impurities contained in calcium folinate.
    Francese G; Corana F; Meneghetti O; Marazza F
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):757-63. PubMed ID: 15927438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of response factor ruggedness for the determination of drug impurities using high-performance liquid chromatography with ultraviolet detection.
    Olsen BA; Argentine MD
    J Chromatogr A; 1997 Feb; 762(1-2):227-33. PubMed ID: 9098981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthogonal method development using hydrophilic interaction chromatography and reversed-phase high-performance liquid chromatography for the determination of pharmaceuticals and impurities.
    Wang X; Li W; Rasmussen HT
    J Chromatogr A; 2005 Aug; 1083(1-2):58-62. PubMed ID: 16078688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of 2,6-dimethylaniline and o-toluidine impurities in preparations for local anaesthesia by the HPLC method with amperometric detection.
    Baczyński E; Piwońska A; Fijałek Z
    Acta Pol Pharm; 2002; 59(5):333-9. PubMed ID: 12602793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.